HK1215396A1 - Methods and compositions for administration of oxybutynin - Google Patents

Methods and compositions for administration of oxybutynin

Info

Publication number
HK1215396A1
HK1215396A1 HK16103431.3A HK16103431A HK1215396A1 HK 1215396 A1 HK1215396 A1 HK 1215396A1 HK 16103431 A HK16103431 A HK 16103431A HK 1215396 A1 HK1215396 A1 HK 1215396A1
Authority
HK
Hong Kong
Prior art keywords
oxybutynin
administration
compositions
methods
Prior art date
Application number
HK16103431.3A
Other languages
Chinese (zh)
Inventor
．庫克
．拜倫
．弗萊明
Original Assignee
Microdose Therapeutx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/728,706 external-priority patent/US9119777B2/en
Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc
Publication of HK1215396A1 publication Critical patent/HK1215396A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16103431.3A 2012-12-27 2016-03-23 Methods and compositions for administration of oxybutynin HK1215396A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/728,706 US9119777B2 (en) 2008-05-30 2012-12-27 Methods and compositions for administration of oxybutynin
PCT/US2013/074759 WO2014105446A1 (en) 2012-12-27 2013-12-12 Methods and compositions for administration of oxybutynin

Publications (1)

Publication Number Publication Date
HK1215396A1 true HK1215396A1 (en) 2016-08-26

Family

ID=51021931

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16103431.3A HK1215396A1 (en) 2012-12-27 2016-03-23 Methods and compositions for administration of oxybutynin
HK16104715.8A HK1216843A1 (en) 2012-12-27 2016-04-25 Methods and compositions for administration of oxybutynin

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16104715.8A HK1216843A1 (en) 2012-12-27 2016-04-25 Methods and compositions for administration of oxybutynin

Country Status (15)

Country Link
EP (1) EP2938329A4 (en)
JP (1) JP2016504358A (en)
KR (1) KR20150100902A (en)
CN (1) CN104955444A (en)
AR (1) AR094287A1 (en)
AU (1) AU2013368298B2 (en)
BR (1) BR112015015421A2 (en)
CA (1) CA2895955A1 (en)
EA (1) EA201591218A1 (en)
HK (2) HK1215396A1 (en)
IL (1) IL239623A0 (en)
MX (1) MX2015008333A (en)
NZ (1) NZ628479A (en)
UY (1) UY35230A (en)
WO (1) WO2014105446A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102094626B1 (en) * 2016-02-25 2020-03-27 히사미쓰 세이야꾸 가부시키가이샤 Liquid for external use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767877B2 (en) * 1999-05-20 2003-11-27 Sepracor, Inc. Methods for treatment of asthma using S-oxybutynin
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
BR0315258A (en) * 2002-10-29 2005-08-23 Pharmacia & Upjohn Co Llc Quaternary ammonium compounds
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
CA2585122A1 (en) * 2004-10-25 2006-05-04 Schering Corporation M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
AU2009241628A1 (en) * 2008-02-26 2009-11-05 Elevation Pharmaceuticals, Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
WO2010147631A1 (en) * 2009-06-16 2010-12-23 Wen Tan Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
TR201811349T4 (en) * 2010-04-01 2018-09-21 Chiesi Farm Spa PROCESS FOR PREPARATION OF DRY POWDER CARRIER PARTICULARS FOR INHALATION.
WO2012047674A2 (en) * 2010-09-27 2012-04-12 Microdose Therapeutx, Inc. Methods and compositions for disease treatment using inhalation

Also Published As

Publication number Publication date
AU2013368298B2 (en) 2016-08-11
AU2013368298A1 (en) 2015-07-02
MX2015008333A (en) 2015-11-09
EA201591218A1 (en) 2015-11-30
AR094287A1 (en) 2015-07-22
HK1216843A1 (en) 2016-12-09
KR20150100902A (en) 2015-09-02
JP2016504358A (en) 2016-02-12
BR112015015421A2 (en) 2017-07-11
NZ628479A (en) 2016-06-24
CN104955444A (en) 2015-09-30
UY35230A (en) 2015-01-30
CA2895955A1 (en) 2014-07-03
IL239623A0 (en) 2015-08-31
WO2014105446A1 (en) 2014-07-03
EP2938329A1 (en) 2015-11-04
EP2938329A4 (en) 2016-08-10

Similar Documents

Publication Publication Date Title
HK1251246A1 (en) Methods and compositions for desulfurization of compositions
ZA201508059B (en) Compositions and methods of use of phorbol esters
EP2836224A4 (en) Compositions of microbiota and methods related thereto
AP3965A (en) Anthelminitic compounds and compositions and method of using thereof
EP2675471A4 (en) Hsa-related compositions and methods of use
HRP20180633T1 (en) Methods for the preparation and delivery of fuel compositions
HK1216503A1 (en) Compositions and methods for transdermal delivery of amphetamine
HK1203815A1 (en) Pharmaceutical compositions and methods for their preparation
EP2897639A4 (en) Improved vaccine compositions and methods of use
HK1203149A1 (en) Novel dosage form and formulation of abediterol
EP2906041A4 (en) Compositions and methods of use of an inappetance-controlling compound
EP2867199A4 (en) Stable compositions of fesoterodine
HK1216843A1 (en) Methods and compositions for administration of oxybutynin
EP2814907A4 (en) Boron-loaded liquid scintillator compositions and methods of preparation thereof
HK1212998A1 (en) Ron compositions and methods of use thereof ron
EP2841164A4 (en) Dermal-appropriate compositions and methods of use
AU2012905317A0 (en) Methods and Preparation and Use of Xanthorrhoeaceae Compositions
AU2012901658A0 (en) Compositions and methods of use